This yearly review analyzes recent developments, trends and outlooks in the areas of biotechnology, biosimilars, biopharmaceuticals, biologics, biomarkers and biobanks.
The 29th edition of the Manny Awards took place on April 19th at Chelsea Piers in New York.
More than 700 pharma leaders attended eyeforpharma Philadelphia 2018 in April to discuss and learn about how the healthcare industry is revolutionizing the patient experience – and, accordingly, companies’ commercial performance. The 16th annual event spanned two days and included more than 123 speakers, 40-plus sessions, and six workshops. The conference is tailored to every […]
Med Ad News talked to Sound Healthcare Communications’ Jeff Hack, managing partner, creative director; Ryan Perkins, managing partner, director of client services; and Nick Rhodin, managing partner, director of strategic planning.
Dr. Julie Gerberding, MD, MPH, was honored as the 2018 Woman of the Year (WOTY) by the Healthcare Businesswomen’s Association. The HBA’s 29th WOTY event was held at the New York Hilton Midtown on Thursday, May 3rd. About 2,500 leaders from throughout the healthcare industry were in attendance. The event additionally recognized the HBA Honorable Mentor, STAR and […]
To qualify for this annual report, agencies must have the capabilities to develop marketing strategies that target healthcare professionals (physicians, nurse practitioners, nurses, pharmacists, etc.), and/or consumers, and/or patients, and/or stakeholders such as managed market payors.
Holding companies/networks and their healthcare communications agencies The Access Group is the parent company of MedAccess of San Diego, medaccessbrands.com The Bloc Partners is a network of affiliated agencies that includes The Bloc of New York, thebloc.com Cello Group plc is the parent company of Cello Health of New York, cellohealth.com Fishawack Group of […]
Med Ad News – the leading pharmaceutical business and marketing publication – reveals the winners for the 2018 Manny Awards, celebrating the healthcare communications industry.
On April 19th, Sharon Callahan is being recognized at the 29th annual Manny Awards as Med Ad News’ Industry Person of the Year.
Med Ad News Announces Finalists for the 2018 Manny Awards and Names Sharon Callahan, CEO of TBWA\WorldHealth, as Industry Person of the Year
Med Ad News announced the nominees for the 29th Annual Manny Awards and named TBWA\WorldHealth CEO Sharon Callahan as the Industry Person of the Year.
Deal activity is rampant as Big Pharma gobbles up next-generation medicines and technologies to help overcome maturing pipelines and biosimilar threats.
Robert Leverte Jr. was honored by the Medical Advertising Hall of Fame as its 2018 inductee on February 8 at a black-tie event at The Pierre Hotel in New York City. Leverte’s prolific career has included founding ERS – an in-house ad agency at ER Squibb – co-founding Ruvane-Leverte advertising, serving as chairman at Bozell Jacobs Medical Group, and operating as CEO of the Leverte Companies.
Executives from 2017 Manny Award winners/finalists and other healthcare communications agencies participated in this Q&A forum of industry topics.
Med Ad News asked the healthcare agency roundtable panel from the magazine’s December 2017 cover story the following question: How is your organization effectively implementing the point-of-care channel to advance health and healthcare outcomes? What are some of the emerging trends in POC communications?
The number of people newly diagnosed with HIV in Europe reached its highest level in 2016 since records began, showing the region’s epidemic growing “at an alarming pace,” health officials said.
For this annual special report, which is in its 31st year of publication, Med Ad News editors rank and profile the world’s top 50 companies that generate revenue from healthcare products.
The healthcare advertising industry’s next generation of leaders, guided by those who have already made it to the top, gathered at the Medical Advertising Hall of Fame’s View From The Top event.
Amgen is featuring an unprecedented collection of new product offerings, including the first-ever biosimilar cancer treatment to receive U.S. marketing clearance.
Management set out a series of new priorities to 2020 to improve innovation, performance and trust in GlaxoSmithKline.
With proven worldwide commercial capabilities and a robust product pipeline, Johnson & Johnson is firmly positioned to continue generating strong, long-term, sustainable growth.